{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01233960",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CRD 611"
      },
      "Organization": {
        "OrgFullName": "Mesoblast, Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease",
      "OfficialTitle": "A Multicenter, Open-label Study to Evaluate the Safety of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects Who Have Received Previous Remestemcel-L Induction Treatment for Treatment-refractory Moderate-to-severe Crohn's Disease"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 29, 2010",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 15, 2014",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 15, 2014",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "November 2, 2010",
      "StudyFirstSubmitQCDate": "November 2, 2010",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 3, 2010",
        "StudyFirstPostDateType": "Estimate"
      },
      "DispFirstSubmitDate": "December 3, 2021",
      "DispFirstSubmitQCDate": "December 3, 2021",
      "DispFirstPostDateStruct": {
        "DispFirstPostDate": "December 8, 2021",
        "DispFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "December 3, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 8, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mesoblast, Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To provide open-label re-treatment with PROCHYMAL to subjects enrolled in companion Protocol 603 to evaluate the safety in subjects with active Crohn's disease who are resistant to standard Crohn's disease therapies.",
      "DetailedDescription": "Subjects will receive infusions of PROCHYMAL on Day 42, Day 84, and Day 126 after initial infusion of PROCHYMAL in Protocol 603. Each infusion will contain 200 million cells. As subjects will be required to be in Protocol 603 during the entire duration of their participation in Protocol 611, all concomitant medication and safety information will be monitored by Protocol 603 and the combination of data from the two protocols"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Crohn's Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Crohn's Disease",
          "Adult Stem Cell Therapy",
          "inflammation of the gastrointestinal tract"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "73",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Prochymal",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Infusions of Prochymal on days 42-45, 84-87, and 126-129 after first infusion in Protocol 603. Each infusion of PROCHYMAL (remestemcel-L) will contain 200 million cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: adult human mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "adult human mesenchymal stem cells",
            "InterventionDescription": "PROCHYMAL will be administered IV in a total volume of 300 ml (200 million cells) at a rate of 4-6 ml/minute. Treatments will be administered on Days 42-45, Days 84-87, and Days 126-129 following first infusion in Protocol 603.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Prochymal"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Prochymal",
                "remestemcel-L"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Disease remission",
            "PrimaryOutcomeDescription": "Crohn's Disease Activity Index (CDAI) at or below 150 and increase in IBDQ",
            "PrimaryOutcomeTimeFrame": "180 Days after first infusion in Protocol 603"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Disease Improvement",
            "SecondaryOutcomeDescription": "CDAI response to treatments is defined as a CDAI of 150 or below, or a reduction in CDAI of at least 100 points.",
            "SecondaryOutcomeTimeFrame": "180 Days after first infusion in Protocol 603"
          },
          {
            "SecondaryOutcomeMeasure": "Improvement in Quality of Life (IBDQ)",
            "SecondaryOutcomeDescription": "IBDQ response to treatment is defined as IBDQ of 170 or above, or an increase in IBDQ of at least 16 points.",
            "SecondaryOutcomeTimeFrame": "180 Days after first infusion in Protocol 603"
          },
          {
            "SecondaryOutcomeMeasure": "Number of Adverse events as a measure of safety",
            "SecondaryOutcomeTimeFrame": "180 Days after first infusion in Protocol 603"
          },
          {
            "SecondaryOutcomeMeasure": "Infusional toxicity as a measure of safety and tolerability",
            "SecondaryOutcomeDescription": "Infusional toxicity will be evaluated by continuously monitoring the subject's vital signs and O2 saturation by pulse oximetry from the time of PROCHYMAL administration until two hours after infusion is complete.",
            "SecondaryOutcomeTimeFrame": "180 Days after first infusion in Protocol 603"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubject must have qualified for, enrolled in, and provided written informed consent form (ICF) and authorization for use and disclosure of protected health information (PHI) for Protocol 603 after the August 3, 2010.\nSubject successfully completed all screening assessments in Protocol 603 as required by Protocol 603.\nSubject successfully completed the full course of each of the four infusions of investigational agent on Days 0, 3, 7, and 14 of Protocol 603 after August 3, 2010.\nSubject must enroll in Protocol 611 on or before the 45th day after first infusion in Protocol 603.\nSubject must provide written ICF and authorization for use and disclosure of PHI for Protocol 611.\n\nExclusion Criteria:\n\nSubject is unwilling or unable to adhere to requirements of Protocol 611.\nSubject had confirmed respiratory distress during a PROCHYMAL infusion in any prior PROCHYMAL study.\nSubject had a serious adverse event in any previous PROCHYMAL study that was deemed by the principal investigator of that study to be possibly or probably related to PROCHYMAL and also that was within 48 h after a PROCHYMAL infusion.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Mahboob Rahman",
            "OverallOfficialAffiliation": "Mesoblast, Inc.",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of California, San Francisco",
            "LocationCity": "San Francisco",
            "LocationState": "California",
            "LocationZip": "94115",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Clinical Research of West Florida",
            "LocationCity": "Clearwater",
            "LocationState": "Florida",
            "LocationZip": "33765",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Shafran Gastroenterology Center",
            "LocationCity": "Winter Park",
            "LocationState": "Florida",
            "LocationZip": "32789",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "University of Chicago",
            "LocationCity": "Chicago",
            "LocationState": "Illinois",
            "LocationZip": "60611",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Cotton-O'Neil Clinical Research Center",
            "LocationCity": "Topeka",
            "LocationState": "Kansas",
            "LocationZip": "66606",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "University of Maryland, Baltimore",
            "LocationCity": "Baltimore",
            "LocationState": "Maryland",
            "LocationZip": "21201",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Chevy Chase Clinical Research",
            "LocationCity": "Chevy Chase",
            "LocationState": "Maryland",
            "LocationZip": "20815",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Saint Louis Center for Clinical Research",
            "LocationCity": "Saint Louis",
            "LocationState": "Missouri",
            "LocationZip": "63128",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "St. Louis Center for Clinical Studies",
            "LocationCity": "Saint Louis",
            "LocationState": "Missouri",
            "LocationZip": "63128",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Dartmouth HItchcock Medical Center",
            "LocationCity": "Lebanon",
            "LocationState": "New Hampshire",
            "LocationZip": "03756",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Weill Cornell Medical College",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10028",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mount Sinai School of Medicine",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10029",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Gastroenterology Center of the Midsouth, PC",
            "LocationCity": "Germantown",
            "LocationState": "Tennessee",
            "LocationZip": "38138",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Vanderbilt University Medical Center",
            "LocationCity": "Nashville",
            "LocationState": "Tennessee",
            "LocationZip": "37232",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Baylor University Medical Center",
            "LocationCity": "Dallas",
            "LocationState": "Texas",
            "LocationZip": "75246",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "McGuire Research Institute",
            "LocationCity": "Richmond",
            "LocationState": "Virginia",
            "LocationZip": "23249",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Royal Adelaide Hospital",
            "LocationCity": "Adelaide",
            "LocationState": "South Australia",
            "LocationCountry": "Australia"
          },
          {
            "LocationFacility": "Royal Melbourne Hospital",
            "LocationCity": "Melbourne",
            "LocationState": "Victoria",
            "LocationCountry": "Australia"
          },
          {
            "LocationFacility": "University of Otago",
            "LocationCity": "Christchurch",
            "LocationCountry": "New Zealand"
          },
          {
            "LocationFacility": "Waikato Hospital",
            "LocationCity": "Hamilton",
            "LocationCountry": "New Zealand"
          }
        ]
      }
    }
  },
  "ResultsSection": {
    "MoreInfoModule": {}
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003424",
            "ConditionMeshTerm": "Crohn Disease"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000015212",
            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
          },
          {
            "ConditionAncestorId": "D000005759",
            "ConditionAncestorTerm": "Gastroenteritis"
          },
          {
            "ConditionAncestorId": "D000005767",
            "ConditionAncestorTerm": "Gastrointestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          },
          {
            "ConditionAncestorId": "D000007410",
            "ConditionAncestorTerm": "Intestinal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9445",
            "ConditionBrowseLeafName": "Inflammation",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5790",
            "ConditionBrowseLeafName": "Crohn Disease",
            "ConditionBrowseLeafAsFound": "Crohn's Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9596",
            "ConditionBrowseLeafName": "Intestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17069",
            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8027",
            "ConditionBrowseLeafName": "Gastroenteritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "C000711674",
            "InterventionMeshTerm": "Remestemcel-l"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000893",
            "InterventionAncestorTerm": "Anti-Inflammatory Agents"
          },
          {
            "InterventionAncestorId": "D000000998",
            "InterventionAncestorTerm": "Antiviral Agents"
          },
          {
            "InterventionAncestorId": "D000000890",
            "InterventionAncestorTerm": "Anti-Infective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M186752",
            "InterventionBrowseLeafName": "Remestemcel-l",
            "InterventionBrowseLeafAsFound": "Solution for inhalation",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M3369",
            "InterventionBrowseLeafName": "Anti-Inflammatory Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3466",
            "InterventionBrowseLeafName": "Antiviral Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3366",
            "InterventionBrowseLeafName": "Anti-Infective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "Infl",
            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}